loader
Please Wait
Applying Filters...

AbbVie Contract Manufacturing AbbVie Contract Manufacturing

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_2003_165___rev_01 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Pharmacosmos AS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Biopharma Group offers CDMO services with expertise in contract R&D for dried products & liquid formulations.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Pharmacosmos A/S Holbaek DK (1)

    filter

    01 Dextran 1 for injection (1)

    filter

    01 Denmark (1)

    filter

    01 Valid (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    Pharmacosmos A/S Holbaek DK

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Denmark
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Dextran 1 for injection

    PDF Supplier PDF
    URL Supplier Web Content
    R1-CEP 2003-165 - Rev 01
    Valid
    Chemical
    2022-01-03
    1506
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2003-165 - Rev 01 of Pharmacosmos A/s Holbaek Dk

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2003-165 - Rev 01 of Pharmacosmos A/s Holbaek Dk 1

    20

    Pharmacosmos A/s Holbaek Dk, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA.

    One of their significant offerings is Dextran 1 for injection, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2003-165 - Rev 01

    This Chemical Type CEP, issued on January 03, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

    Substance Number 1506 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY